首页> 外国专利> METHOD FOR PREVENTION OF DEVELOPMENT OF CRDIOVASCULAR COMPLICATIONS AT THE CHRONIC KIDNEY DISEASES

METHOD FOR PREVENTION OF DEVELOPMENT OF CRDIOVASCULAR COMPLICATIONS AT THE CHRONIC KIDNEY DISEASES

机译:预防慢性肾脏病患者心血管并发症的方法

摘要

A method for prevention of development of crdiovascular complications at the chronic kidney diseases is carried out, performing the biochemical study of blood and urine. At that, except the conventional clinical-and-laboratory indexes, the level of glomerular filtration rate (GFR), the control indexes of the functional state of vessel endothelia, are determined and assessed in the blood and urine. The conventional drugs are prescribed in a therapeutically effective and safe amount during 2 weeks. The activities of untripsin proteinase (UTP) and calpains are determined as the control indexes, which characterize the development of structural abnormalities of kidney vessel endothelium (vasoconstriction, atherosclerosis). If in comparison with the initial values of UTP activity grows in the blood serum and does not change in urine, it testifies to development of vasoconstriction and the drugs from the group of ACE inhibitor with lipophilic properties are prescribed. If the calpain activity grows in the blood serum and goes down in urine, it testifies to the formation of initial phase of atherosclerotic affect of kidney vessel endothelium and additionally to base therapy the hypolipidemic agents (statines) are prescribed at a dose, adjusted on the UTP level.
机译:进行了预防慢性肾脏疾病中的颅血管并发症发展的方法,进行了血液和尿液的生化研究。那时,除了常规的临床和实验室指标外,还要在血液和尿液中确定并评估肾小球滤过率(GFR)的水平,血管内皮功能状态的控制指标。常规药物在2周内以治疗有效和安全的量开出处方。确定解曲蛋白蛋白酶(UTP)和钙蛋白酶的活性作为对照指标,其表征肾血管内皮结构异常(血管收缩,动脉粥样硬化)的发展。如果UTP活性的初始值与血清中的UTP活性相比有所增长,而尿液中没有变化,则表明血管收缩的发展,并开出了具有亲脂性的ACE抑制剂药物。如果钙蛋白酶活性在血清中增加而在尿液中下降,则表明肾脏血管内皮的动脉粥样硬化作用的初始阶段的形成,此外,在基础治疗中,应根据剂量调整降血脂药(他汀类药物)的剂量。 UTP级别。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号